SCHEMBL31528032

SCHEMBL31528032

CC(=Cc1nc(-c2ccc(Oc3ccc(Cl)cn3)cc2)no1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 3/20 0.44
▸ FPR2 P25090 1/20 0.44
▸ LTA4H P09960 1/20 0.43
▸ LIPE Q05469 1/20 0.43
▸ LMNA P02545 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ KMT2A Q03164 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.39
▸ DGAT1 O75907 1/20 0.38
▸ SOAT1 P35610 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ FFAR1 O14842 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ ACACB O00763 5/20 0.38
▸ PPARD Q03181 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31527969 0.82 LMNA (0.42) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL31527941 0.82 LMNA (0.40) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL31527936 0.80 PPARD (0.46) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL31527942 0.80 LMNA (0.42) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL31528002 0.79 LMNA (0.44) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL31527883 0.79 PPARD (0.41) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL31527952 0.78 LMNA (0.43) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL31527925 0.76 LMNA (0.46) LMNARAB9ATSHRNFKB1NFKB2
SCHEMBL23588190 0.76 ACACB (0.50) RAB9ATSHRHTTACACBPPARD
SCHEMBL31527933 0.76 LMNA (0.42) LMNARAB9ATSHRNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968366-A Oxadiazole derivatives, methods of preparation and use thereof in the treatment of inflammatory diseases 西特瑞治疗有限公司 2025-05-09 — — CN claimed
Send feedback